| 发明名称 |
Use of egfr transactivation inhibitors in human cancer |
| 摘要 |
The present invention relates to the use of a compound which is capable of inhibiting activation of a growth factor receptor of the EGFR-family for the prevention or treatment of processes associated with increased G-protein mediated signal transduction.
|
| 申请公布号 |
US2005176633(A1) |
申请公布日期 |
2005.08.11 |
| 申请号 |
US20050506962 |
申请日期 |
2005.04.19 |
| 申请人 |
ULLRICH AXEL;SCHAEFER BEATRIX;FISCHER OLIVER;GSCHWIND ANDREAS;LESERER MICHAEL |
发明人 |
ULLRICH AXEL;SCHAEFER BEATRIX;FISCHER OLIVER;GSCHWIND ANDREAS;LESERER MICHAEL |
| 分类号 |
A61K31/16;A61K31/381;A61K38/16;A61K38/18;A61K38/48;A61K38/55;C07K16/28;(IPC1-7):A61K39/395 |
主分类号 |
A61K31/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
